Frazier Life Sciences Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Frazier Life Sciences Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10M	Hold	500,333	–	–	0.26%	34
2025 Q4	$11.5M	Hold	500,333	–	–	0.31%	34
2025 Q3	$8.56M	Hold	500,333	–	–	0.26%	41
2025 Q2	$4M	Hold	500,333	–	–	0.16%	46
2025 Q1	$4.5M	Hold	500,333	–	–	0.21%	43
2024 Q4	$7.13M	Hold	500,333	–	–	0.3%	43
2024 Q3	$3.5M	Hold	500,333	–	–	0.14%	49
2024 Q2	$4.36M	Hold	500,333	–	–	0.2%	45
2024 Q1	$5.52M	Hold	500,333	–	–	0.23%	45
2023 Q4	$1.57M	Hold	500,333	–	–	0.08%	48
2023 Q3	$951K	Hold	500,333	–	–	0.06%	52
2023 Q2	$1.05M	Hold	500,333	–	–	0.06%	48
2023 Q1	$921K	Hold	500,333	–	–	0.07%	48
2022 Q4	$434K	Buy	+500,333	New	+$412K	0.03%	43

Other funds holding NAMSW

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Frazier Life Sciences Management's NAMSW Position: Q1 2026 in Review

Frazier Life Sciences Management held its NewAmsterdam Pharma Warrant (NAMSW) position steady in Q1 2026 at 500,333 shares worth $10M. The position accounts for 0.26% of the portfolio, ranked #34.

Frazier Life Sciences Management first reported a position in NAMSW in Q4 2022 and has held it in 14 quarters since. The position peaked at $11.5M in Q4 2025. 9 funds tracked by Wall St. Rank hold NAMSW as of Q1 2026.

Frazier Life Sciences Management held 500,333 shares of NewAmsterdam Pharma Warrant worth $10M as of Q1 2026.
Frazier Life Sciences Management left its NewAmsterdam Pharma Warrant share count unchanged in Q1 2026.
NewAmsterdam Pharma Warrant made up 0.26% of Frazier Life Sciences Management's portfolio in Q1 2026, its #34 holding.
Frazier Life Sciences Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and has held it in 14 quarters since.
Frazier Life Sciences Management's NewAmsterdam Pharma Warrant position peaked at $11.5M in Q4 2025.
9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2026.

Based on Frazier Life Sciences Management's 13F filing for Q1 2026, filed 15 May 2026.